Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
May 04, 2023 at 06:58 AM EDT
Moderna maintained its full-year guidance of around $5 billion in revenue from its Covid vaccine, its only marketable product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|